IS6567A - Natríum-vetnis skiptilati af gerð 1 (NHE-1) - Google Patents

Natríum-vetnis skiptilati af gerð 1 (NHE-1)

Info

Publication number
IS6567A
IS6567A IS6567A IS6567A IS6567A IS 6567 A IS6567 A IS 6567A IS 6567 A IS6567 A IS 6567A IS 6567 A IS6567 A IS 6567A IS 6567 A IS6567 A IS 6567A
Authority
IS
Iceland
Prior art keywords
nhe
interlayer
sodium
hydrogen type
hydrogen
Prior art date
Application number
IS6567A
Other languages
English (en)
Inventor
George Chen Weichao
David Cox Eric
Guzman-Perez Angel
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of IS6567A publication Critical patent/IS6567A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Plural Heterocyclic Compounds (AREA)
IS6567A 2000-04-28 2002-09-24 Natríum-vetnis skiptilati af gerð 1 (NHE-1) IS6567A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20043200P 2000-04-28 2000-04-28
PCT/IB2001/000277 WO2001083470A1 (en) 2000-04-28 2001-02-28 Sodium-hydrogen exchanger type 1 inhibitor (nhe-1)

Publications (1)

Publication Number Publication Date
IS6567A true IS6567A (is) 2002-09-24

Family

ID=22741697

Family Applications (2)

Application Number Title Priority Date Filing Date
IS6567A IS6567A (is) 2000-04-28 2002-09-24 Natríum-vetnis skiptilati af gerð 1 (NHE-1)
IS6588A IS6588A (is) 2000-04-28 2002-10-21 Natríum-vetnis skiptis hindri af gerð 1 (NHE-1)

Family Applications After (1)

Application Number Title Priority Date Filing Date
IS6588A IS6588A (is) 2000-04-28 2002-10-21 Natríum-vetnis skiptis hindri af gerð 1 (NHE-1)

Country Status (40)

Country Link
EP (1) EP1276737A1 (is)
JP (1) JP2003531900A (is)
KR (1) KR20020093079A (is)
CN (1) CN1225466C (is)
AP (1) AP2002002651A0 (is)
AR (1) AR028375A1 (is)
AU (1) AU2001235896A1 (is)
BG (1) BG107139A (is)
BR (1) BR0110268A (is)
CA (1) CA2407535A1 (is)
CO (1) CO5221125A1 (is)
CR (1) CR6797A (is)
CZ (1) CZ20023408A3 (is)
DZ (1) DZ3310A1 (is)
EA (1) EA004882B1 (is)
EE (1) EE200200615A (is)
GT (1) GT200100064A (is)
HN (1) HN2001000042A (is)
HR (1) HRP20020851A2 (is)
HU (1) HUP0300651A2 (is)
IL (1) IL152075A0 (is)
IS (2) IS6567A (is)
MA (1) MA26897A1 (is)
MX (1) MXPA02010600A (is)
MY (1) MY133842A (is)
NO (1) NO20025132L (is)
NZ (1) NZ521348A (is)
OA (1) OA12256A (is)
PA (1) PA8513301A1 (is)
PE (1) PE20011270A1 (is)
PL (1) PL357765A1 (is)
SK (1) SK14872002A3 (is)
SV (1) SV2002000418A (is)
TN (1) TNSN01065A1 (is)
TR (1) TR200202439T2 (is)
UA (1) UA73348C2 (is)
UY (1) UY26680A1 (is)
WO (1) WO2001083470A1 (is)
YU (1) YU79602A (is)
ZA (1) ZA200208605B (is)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2436539A1 (en) * 2001-01-31 2002-08-08 Pfizer Products Inc. Ethanolates of sodium-hydrogen exchanger type-1 inhibitor
MXPA04004685A (es) * 2001-12-19 2004-08-12 Pfizer Prod Inc Procedimientos para preparar inhibidores de tipo-1 de intercambiador sodio-hidrogeno.
EP1499317A1 (en) * 2002-05-02 2005-01-26 Pfizer Products Inc. Treatment of diabetes and diabetic complications with nhe-1 inhibitors
FR2840302B1 (fr) * 2002-06-03 2004-07-16 Aventis Pharma Sa Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
ES2220185B1 (es) * 2002-07-16 2006-04-01 Consejo Sup. De Investig. Cientificas Nuevo peptido inhibidor del intercambiador na+/h+ (pinhe), y sus aplicaciones.
CA2515939A1 (en) * 2003-02-14 2004-09-02 Smithkline Beecham Corporation Novel compounds
RU2518741C1 (ru) * 2013-03-22 2014-06-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" СРЕДСТВО, ИНГИБИРУЮЩЕЕ Na+/H+-ОБМЕН, И ГАЛОГЕНИДЫ 1-ДИАЛКИЛАМИНОЭТИЛ-3-[ЗАМЕЩЕННЫЙ(ДИЗАМЕЩЕННЫЙ) ФЕНАЦИЛ]-2-АМИНОБЕНЗИМИДАЗОЛИЯ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002504546A (ja) * 1998-02-27 2002-02-12 ファイザー・プロダクツ・インク 虚血の治療のためのｎ−［（置換５員ジもしくはトリアザ二不飽和環）カルボニル］グアニジン誘導体

Also Published As

Publication number Publication date
ZA200208605B (en) 2003-10-24
UY26680A1 (es) 2001-12-28
HRP20020851A2 (en) 2005-02-28
MXPA02010600A (es) 2003-03-10
CN1426404A (zh) 2003-06-25
GT200100064A (es) 2002-03-22
HN2001000042A (es) 2001-07-09
MA26897A1 (fr) 2004-12-20
YU79602A (en) 2006-05-25
CR6797A (es) 2004-05-17
EP1276737A1 (en) 2003-01-22
CO5221125A1 (es) 2002-11-28
IL152075A0 (en) 2003-05-29
BG107139A (bg) 2003-07-31
WO2001083470A1 (en) 2001-11-08
JP2003531900A (ja) 2003-10-28
MY133842A (en) 2007-11-30
NZ521348A (en) 2004-09-24
UA73348C2 (en) 2005-07-15
IS6588A (is) 2002-10-21
TR200202439T2 (tr) 2003-02-21
BR0110268A (pt) 2003-12-30
EE200200615A (et) 2004-04-15
PL357765A1 (en) 2004-07-26
SV2002000418A (es) 2002-07-03
AR028375A1 (es) 2003-05-07
AU2001235896A1 (en) 2001-11-12
PE20011270A1 (es) 2001-12-12
PA8513301A1 (es) 2003-09-05
NO20025132L (no) 2002-12-12
OA12256A (en) 2003-11-06
AP2002002651A0 (en) 2002-12-31
CA2407535A1 (en) 2001-11-08
CZ20023408A3 (cs) 2004-01-14
CN1225466C (zh) 2005-11-02
DZ3310A1 (fr) 2001-11-07
KR20020093079A (ko) 2002-12-12
EA200201023A1 (ru) 2003-02-27
HUP0300651A2 (hu) 2003-07-28
SK14872002A3 (sk) 2004-03-02
NO20025132D0 (no) 2002-10-25
TNSN01065A1 (fr) 2005-11-10
EA004882B1 (ru) 2004-08-26

Similar Documents

Publication Publication Date Title
NO20030845L (no) Utvalgte kondenserte pyrrolokarbazoler
DE60143412D1 (de) Oberfräse
DE60129364D1 (de) Schmelzsicherung
DE60122878D1 (de) Sicherungseinsatz
FR2818008B1 (fr) Porte-fusibles modulaire
DK1226127T3 (da) Substituerede phenylsulfamoylcarboxamider
DE60114153D1 (de) Substituierte arylpyrazine
AR028393A1 (es) Iminoazidas substituidas
DE50110260D1 (de) Kühlkreislauf
FI20002408L (fi) Jäähdytyselementti
DE50112662D1 (de) Substituierte benzoylcyclohexenone
FI20002454A0 (fi) Lämmönsiirrin
NO20012448L (no) Stigerördiameter-velger
DE60127966D1 (de) Schaltungsanordnung
IS6588A (is) Natríum-vetnis skiptis hindri af gerð 1 (NHE-1)
FR2815472B1 (fr) Diac planar
DE60122192D1 (de) Schaltungsanordnung
EP1273914A4 (en) hypotensors
DE50101588D1 (de) Klemmstück
DE69903130D1 (de) Ausklappbarer bügeltisch
DE60112941D1 (de) Schaltungsanordnung
FI19992301L (fi) Z-moottori
DE60117837D1 (de) Schaltungsanordnung
DE60113842D1 (de) Schaltung
FI20002648A0 (fi) Lämmönsiirrin